Thomas L Little, Jr

This inventor holds 29 USPTO granted patents and 15 published patent applications and 2 EPO patents, primarily in Pharmaceutical Research. Top assignees: Acucela Inc., Omeros Corporation, Agouron Pharmaceuticals, Inc.. Active years: 1991-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas L Little, Jr. Retrieved from https://idiyas.com/inventor/thomas-l-little-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 15)

% Patents Active = 72.4

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 104(Granted Patents)

Location History:

Oxford, MS (US) (1991)
Redmond, WA (US) (1999 - 2016)
Seattle, WA (US) (2016 - 2024)

Company Filing History:

Agouron Pharmaceuticals, Inc.

patents

4. 1 out of 1

Wilmington Savings Fund Society, Fsb, as Collateral Agent

patent

5. 1 out of 834,570

Other

patents

Years Active: 1991-2026

Loading Chart...

Areas of Expertise:

MASP-2 Inhibitors

PDE10 Inhibitors

Alkoxy Compounds

Styrenyl Derivatives

Ophthalmic Diseases

Antipicornaviral Compounds

Deuterated Cannabinoids

Disease Treatment

Solid State Forms

Preparation Processes

Amine Derivatives

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12703684 - MASP-2 INHIBITORS AND METHODS OF USE (2026-08-11),

2. 12692229 - MASP-2 INHIBITORS AND METHODS OF USE (2026-07-28),

3. 12486278 - MASP-2 INHIBITORS AND METHODS OF USE (2025-12-02),

4. 12195427 - MASP-2 inhibitors and methods of use (2025-01-14),

5. 12110288 - MASP-2 inhibitors and methods of use (2024-10-08),

6. 12030853 - MASP-2 inhibitors and methods of use (2024-07-09),

7. 12029708 - Alkoxy compounds for disease treatment (2024-07-09),

8. 11807641 - MASP-2 inhibitors and methods of use (2023-11-07),

9. 11661418 - MASP-2 inhibitors and methods of use (2023-05-30),

10. 11584714 - MASP-2 inhibitors and methods of use (2023-02-21),

11. 11446261 - Alkoxy compounds for disease treatment (2022-09-20),

12. 10639286 - Alkoxy compounds for disease treatment (2020-05-05),

13. 10201545 - Styrenyl derivative compounds for treating ophthalmic diseases and disorders (2019-02-12),

14. 10188615 - Alkoxy compounds for disease treatment (2019-01-29),

15. 10106516 - PDE10 inhibitors and related compositions and methods (2018-10-23),

Title: Thomas L Little, Jr: Innovator in Pharmaceutical Patents

Introduction: Thomas L Little, Jr. is a prominent inventor based in Seattle, Washington, with an impressive portfolio of 25 patents to his name. His work primarily focuses on innovative compounds and methods in the pharmaceutical domain, particularly in the area of MASP-2 inhibitors.

Latest Patents: Among his notable contributions are the latest patents related to MASP-2 inhibitors and methods of use. These patents disclose various compounds exhibiting MASP-2 inhibitory activity, as well as the compositions of these compounds and the methods for their use and production. His work in this field highlights his dedication to advancing therapeutic options and improving health outcomes.

Career Highlights: Throughout his career, Thomas has made significant strides in the pharmaceutical industry, particularly during his tenure at Acucela Inc. and Omeros Corporation. His innovative mindset and commitment to research have allowed him to develop groundbreaking solutions that contribute to the medical field.

Collaborations: Thomas has collaborated with several notable individuals, including Jennifer Lynn Gage and Mark W Orme. These partnerships have enabled the sharing of knowledge and expertise, further enriching the innovation landscape within which he operates.

Conclusion: Thomas L Little, Jr. exemplifies the spirit of innovation in the realm of pharmaceuticals. With his extensive patent portfolio and notable collaborations, he continues to make significant contributions to the advancement of medical treatments. His work not only showcases his expertise but also his dedication to improving lives through science and innovation.

Profile summary based on public USPTO records.